Study Physician

من الإعلان الأصلي

Leiden Development ProQR Therapeutics is a NASDAQ-listed biotechnology company headquartered in Leiden, the Netherlands, with an office in Cambridge, Massachusetts, USA, developing innovative RNA-editing medicines through its proprietary Axiomer™ platform. Our mission is to edit RNA, treat disease and change lives by advancing transformative therapies for patients with currently untreatable conditions. Our Clinical Development team translates scientific innovation into rigorous clinical studies and development programs, with a focus on first-in-human and early-phase trials in rare diseases.…